These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 9721853

  • 21. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma.
    Ueta T, Ikeguchi M, Hirooka Y, Kaibara N, Terada T.
    Oncol Rep; 2002; 9(6):1197-203. PubMed ID: 12375019
    [Abstract] [Full Text] [Related]

  • 22. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
    Chen YW, Jeng YM, Yeh SH, Chen PJ.
    Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
    [Abstract] [Full Text] [Related]

  • 23. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagneré AM, René-Corail F, Jullian E, Gicquel C, Bertagna X, Vacher-Lavenu MC, Perret C, Bertherat J.
    Cancer Res; 2005 Sep 01; 65(17):7622-7. PubMed ID: 16140927
    [Abstract] [Full Text] [Related]

  • 24. Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas.
    Samowitz WS, Powers MD, Spirio LN, Nollet F, van Roy F, Slattery ML.
    Cancer Res; 1999 Apr 01; 59(7):1442-4. PubMed ID: 10197610
    [Abstract] [Full Text] [Related]

  • 25. Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix.
    Shinohara A, Yokoyama Y, Wan X, Takahashi Y, Mori Y, Takami T, Shimokawa K, Tamaya T.
    Gynecol Oncol; 2001 Sep 01; 82(3):450-5. PubMed ID: 11520139
    [Abstract] [Full Text] [Related]

  • 26. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway.
    Torbenson M, Lee JH, Choti M, Gage W, Abraham SC, Montgomery E, Boitnott J, Wu TT.
    Mod Pathol; 2002 Mar 01; 15(3):189-96. PubMed ID: 11904335
    [Abstract] [Full Text] [Related]

  • 27. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
    Wu R, Zhai Y, Fearon ER, Cho KR.
    Cancer Res; 2001 Nov 15; 61(22):8247-55. PubMed ID: 11719457
    [Abstract] [Full Text] [Related]

  • 28. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations.
    Iwao K, Nakamori S, Kameyama M, Imaoka S, Kinoshita M, Fukui T, Ishiguro S, Nakamura Y, Miyoshi Y.
    Cancer Res; 1998 Mar 01; 58(5):1021-6. PubMed ID: 9500465
    [Abstract] [Full Text] [Related]

  • 29. Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma.
    Schlosshauer PW, Pirog EC, Levine RL, Ellenson LH.
    Mod Pathol; 2000 Oct 01; 13(10):1066-71. PubMed ID: 11048799
    [Abstract] [Full Text] [Related]

  • 30. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
    Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A, Rimm DL, Costa J, Fearon ER.
    Cell Growth Differ; 1999 Jun 01; 10(6):369-76. PubMed ID: 10392898
    [Abstract] [Full Text] [Related]

  • 31. Molecular and biological analysis of carcinoma of the small intestine: beta-catenin gene mutation by interstitial deletion involving exon 3 and replication error phenotype.
    Murata M, Iwao K, Miyoshi Y, Nagasawa Y, Ohta T, Shibata K, Oda K, Wada H, Tominaga S, Matsuda Y, Ohsawa M, Nakamura Y, Shimano T.
    Am J Gastroenterol; 2000 Jun 01; 95(6):1576-80. PubMed ID: 10894600
    [Abstract] [Full Text] [Related]

  • 32. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
    Ishizaki Y, Ikeda S, Fujimori M, Shimizu Y, Kurihara T, Itamoto T, Kikuchi A, Okajima M, Asahara T.
    Int J Oncol; 2004 May 01; 24(5):1077-83. PubMed ID: 15067328
    [Abstract] [Full Text] [Related]

  • 33. Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm.
    Tanaka Y, Kato K, Notohara K, Hojo H, Ijiri R, Miyake T, Nagahara N, Sasaki F, Kitagawa N, Nakatani Y, Kobayashi Y.
    Cancer Res; 2001 Dec 01; 61(23):8401-4. PubMed ID: 11731417
    [Abstract] [Full Text] [Related]

  • 34. Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ?
    Gad S, Teboul D, Lièvre A, Goasguen N, Berger A, Beaune P, Laurent-Puig P.
    BMC Cancer; 2004 Jul 09; 4():31. PubMed ID: 15245581
    [Abstract] [Full Text] [Related]

  • 35. Sporadic medulloblastomas contain oncogenic beta-catenin mutations.
    Zurawel RH, Chiappa SA, Allen C, Raffel C.
    Cancer Res; 1998 Mar 01; 58(5):896-9. PubMed ID: 9500446
    [Abstract] [Full Text] [Related]

  • 36. Beta-catenin mutations in human prostate cancer.
    Voeller HJ, Truica CI, Gelmann EP.
    Cancer Res; 1998 Jun 15; 58(12):2520-3. PubMed ID: 9635571
    [Abstract] [Full Text] [Related]

  • 37. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
    Bläker H, Sutter C, Kadmon M, Otto HF, Von Knebel-Doeberitz M, Gebert J, Helmke BM.
    Genes Chromosomes Cancer; 2004 Oct 15; 41(2):93-8. PubMed ID: 15287021
    [Abstract] [Full Text] [Related]

  • 38. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
    Legoix P, Bluteau O, Bayer J, Perret C, Balabaud C, Belghiti J, Franco D, Thomas G, Laurent-Puig P, Zucman-Rossi J.
    Oncogene; 1999 Jul 08; 18(27):4044-6. PubMed ID: 10435629
    [Abstract] [Full Text] [Related]

  • 39. Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis.
    Torbenson M, Lee JH, Cruz-Correa M, Ravich W, Rastgar K, Abraham SC, Wu TT.
    Mod Pathol; 2002 Jul 08; 15(7):718-23. PubMed ID: 12118109
    [Abstract] [Full Text] [Related]

  • 40. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.
    Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, Pietsch T.
    Cancer Res; 1999 Jan 15; 59(2):269-73. PubMed ID: 9927029
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.